3SARAF A,MIKOS A G.Gene delivery strategies for cartilage tissue engineering[J].Adv Drug Deliv Revi, 2006, 58(4):592-603.
4Das A, Neher JO, Safranek S. Clinical inquiries.. Do hyal- uronic acid injections relieve OA knee pain[J]. J Faro Pract, 2009, 58(5): 281-283.
5HUNTER D J. Imaging insights on the epidemiology and pathophysiology of osteoarthritis [J]. Rheum Dis Clin North Am, 2009,3 : 447-463.
6GIANNINI E H, RUPERTO N, RAVELLI A,et al. Pre- liminary definition of improvement in juvenile arthritis [J].arthritis Rheum, 1997,40:1202-1209.
7SANDRA K,LEO A B J,ALISON M B,et al. Different roles of tumour necrosis factor-a and interleukin-1 in murine strep- tococcal cell wall arthritis[J]. Cytokine, 1998,10 : 690-702.
8WEI L, SUN J, WANG Z, et al. CD95-induced osteoarthritic chondrocyte apoptosis and necrosis:dependency on p38 mitogen-activated protein kinase[J]. Arthritis Res T- her, 2006,8 : 37-46.
9PARGELLIS C,REGAN J. Inhibitors of p38 mitogen-ae tivated protein kinase for the treatment of rheumatoid ar thritis[J]. Curr Opin Investig Drugs,2003,4:566-571.
10WESTRA J C,LIMBURG P. p38 mitogen-activated protein kinase (MAPK) in rheumatoid arthritis[J]. Med Chem,2006,6(8) :867-874.
